21 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
to Planet Financial Performance Values-Based Governance Global Corporate Social Responsibility Legal Disclaimers Appendix Reconciliations 03 06 08 09 … , more than 60% of our research and development (R&D) pipeline is being developed with partners around the world. We have 16 Global Corporate Social Responsibility Program
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:01am
workplaces. Takeda’s ESG commitment – including its Access to Medicines strategy and Global Corporate Social Responsibility Program – is evident through
6-K
oqtlzvvfktw2v5nfpgqz
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
ta5o6ls7lr
17 Dec 20
Current report (foreign)
6:01am
6-K
s07ppddjnkyyv
29 Jul 20
Current report (foreign)
6:07am
6-K
EX-1
iqbsh
27 May 20
Current report (foreign)
6:03am
6-K
zeb ls5gp5wavmk7qodp
13 May 20
Current report (foreign)
6:03am
6-K
y1hyhk60rcw9ohmd8vu
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
9h5q9dr
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
njqkz6b
14 Nov 19
Current report (foreign)
6:26am
424B3
c5gx0jtj3p7ydoec
14 Nov 19
Prospectus supplement
6:10am
F-4/A
7ww89sc451cv04cgmsr
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
rs3zg
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
g4zwbqbbdo
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
723e2hh6x3yt3x2wy
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
f045kuo
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am